SMMT Earnings

Quarterly EPS
$-0.08
Q3 2024
$-0.08
Q4 2024
$-0.09
Q1 2025
$-0.76
Q2 2025
$-0.31
Q3 2025
$-0.29
Q4 2025
$-0.24
Q1 2026
$-0.28
Q2 2026
Latest RevenueN/A
Latest Net Income-215666000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.280-215666000+63.2%
Q1 2026-$0.240-189424000-166.7%
Q4 2025-$0.290-219172000-262.5%
Q3 2025-$0.310-231793000-287.5%
Q2 2025-$0.760-565897000-744.4%
Q1 2025-$0.090-62913000-50.0%
Q4 2024-$0.080-61203000-60.0%
Q3 2024-$0.080-56254000-166.7%
Q2 2024-$0.090-60385000
Q1 2024-$0.060-43473000
Q4 2023-$0.050-36567000
Q3 2023-$0.030-21268000
Summit Therapeutics (SMMT) — Earnings